Abstract
Background: Acute myocardial infarction (AMI) in young individuals without traditional cardiovascular risk factors is rare and should prompt evaluation for unusual causes. One such infrequent etiology is chronic myeloproliferative neoplasms (MPNs). Case Report: We present the case of a 33-year-old man admitted with non-ST elevation acute coronary syndrome (NSTE-ACS). Coronary angiography revealed no obstructive lesions, leading to a diagnosis of MINOCA (myocardial infarction with non-obstructive coronary arteries). A chest CT scan ruled out acute aortic syndrome but detected thrombi in the aorta and right common iliac artery. Laboratory studies revealed persistent thrombocytosis for at least four years, suggesting a chronic MPN. Further investigations—including autoimmune and thrombophilia screening, JAK2 mutation testing, and bone marrow biopsy—confirmed the diagnosis of polycythemia vera. Anticoagulation therapy was initiated. MPNs are known to increase the risk of both venous and arterial thrombotic events, including AMI and large-vessel thrombosis. These complications are associated with high morbidity and mortality, even in the absence of conventional cardiovascular risk factors. Conclusion: In young patients presenting with AMI or arterial thrombosis without identifiable cardiovascular risk factors, especially when persistent hematologic abnormalities are found, an underlying myeloproliferative neoplasm should be considered. Early diagnosis is crucial to guide appropriate management and reduce the risk of recurrence.
References
Hernández Boluda JC; Álvarez Larrán A. Manual of Recommendations in Philadelphia-negative chronic myeloproliferative neoplasms. 3ª ed. España; 2020.
Falanga A, Marchetti M. Thrombotic disease in the myeloproliferative neoplasms. Hematology Am Soc Hematol Educ Program. 2012;2012:571-81. doi: 10.1182/asheducation-2012.1.571. PMID: 23233637.
Cerquozzi S, Barraco D, Lasho T, et al. Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients. Blood Cancer J. 2017;7(12):662. Published 2017 Dec 27. doi:10.1038/s41408-017-0035-6
Cengiz B, Aytekin V, Bildirici U, Sahin ST, Yurdakul S, Aytekin S, Kucukkaya R. A rare cause of acute coronary syndromes in young adults - myeloproliferative neoplasms: A case series. Rev Port Cardiol (Engl Ed). 2019 Sep;38(9):613-617. English, Portuguese. doi: 10.1016/j.repc.2018.09.014. Epub 2019 Nov 27. PMID: 31784298
Cantoni S, Colombo C, Soriano F, Oreglia JA, Sacco A, Veronese S, Brunelli D, Rubboli A, Morici N. Rare Causes of Acute Coronary Syndrome: The JAK2 V617F Mutation-Positive Myeloproliferative Neoplasms: A Cardio-Hematological Perspective. Thromb Haemost. 2022 Aug;122(8):1429-1431. doi: 10.1055/a-1742-0361. Epub 2022 Jan 17. PMID: 35038762.
Silveira, C. F. da S. M. P. da, Vitali, L. B. S. L., Faustino, F. G., Maurício, A. D. C. V., Teixeira, R., and Bazan, S. G. Z. Infarto Agudo do Miocárdio como Primeira Manifestação da Policitemia Vera. Arquivos Brasileiros de Cardiologia, 114(4 suppl 1), 27–30.
Lange SA, Schliemann C, Engelbertz C, Feld J, Makowski L, Gerß J, Dröge P, Ruhnke T, Günster C, Reinecke H, Köppe J. Survival of Patients with Acute Coronary Syndrome and Hematologic Malignancies-A Real-World Analysis. Cancers (Basel). 2023 Oct 12;15(20):4966. doi: 10.3390/cancers15204966. PMID: 37894332; PMCID: PMC10605274.
Wang ZM, Chen WH, Wu YM, Wang LQ, Ye FL, Yin RL. Essential thrombocythemia with non-ST-segment elevation myocardial infarction as the first manifestation: A case report. World J Clin Cases. 2022 Jul 26;10(21):7422-7428. doi: 10.12998/wjcc.v10.i21.7422. PMID: 36158029; PMCID: PMC9353925.
Tefferi A, Barbui T. Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management. Am J Hematol. 2023 Sep;98(9):1465-1487. doi: 10.1002/ajh.27002. Epub 2023 Jun 26. PMID: 37357958.
Sohn V, Arthurs Z, Andersen C, Starnes B. Aortic Thrombus due to Essential Thrombocytosis: Strategies for Medical and Surgical Management. Annals of Vascular Surgery, (2008), 676-680, 22(5)
Pinardo Zabala A, Ponce Cano A, Mayoralas Tendero A, et al. Floating aortic thrombus associated with polycythemia vera. Medicina Clinica Practica, (2019), 103, 2(5)
Wolf A, Fajer S, Haddad M, Shnaker A, Ajaj M, Shehab M. A Mobile Thrombus of the Thoracic Aorta. Vasc Endovascular Surg. 2023 Feb;57(2):159-163. doi: 10.1177/15385744221130863. Epub 2022 Sep 28. PMID: 36169285.
Fayad ZY, Semaan E, Fahoum B, Briggs M, Tortolani A, D'Ayala M. Aortic mural thrombus in the normal or minimally atherosclerotic aorta. Ann Vasc Surg. 2013 Apr;27(3):282-90. doi: 10.1016/j.avsg.2012.03.011. Epub 2012 Aug 25. PMID: 22929167.
Fukuhara S, Tyagi S, Clarke-Pearson E, Bernik T. Endovascular stent graft repair of thoracic aortic mural thrombus in a patient with polycythemia vera: a word of caution. Vascular. 2015 Feb;23(1):89-92. doi: 10.1177/1708538114525154. Epub 2014 Feb 25. PMID: 24569113.
Ye S, Xia WJ, Chen P. Case Report: A Rare Case of Acute Anterior Myocardial Infarction Simultaneously Associated With Aortic Mural Thrombosis Due to Essential Thrombocytosis. Front Cardiovasc Med. 2022 Feb 23;9:840906. doi: 10.3389/fcvm.2022.840906. PMID: 35282362; PMCID: PMC8904716.
Fang M, Agha S, Lockridge L, Lee R, Cleary JP, Mazur EM. Medical management of a large aortic thrombus in a young woman with essential thrombocythemia. Mayo Clin Proc. 2001 Apr;76(4):427-31. doi: 10.4065/76.4.427. PMID: 11322360.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2025 Paula Hernández-Sanjuán, Lucía Gandía-Blanquer, Marina Vidal-Pelayo, Miguel Ángel Vázquez-Ronda, Alba Vilches-Moreno, Jorge Francisco Gómez-Cerezo